Barnett & Company’s Accendra Health ACH Stock Holding History

Barnett & Company’s Portfolio ACH Stock Details ACH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-1,050	Closed	-$17K	–	340
2018 Q3	$17K	Buy	+1,050	New	+$17.8K	0.01%	262

Other funds holding ACH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

PPA

Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Barnett & Company's ACH Position: Q4 2018 in Review

Barnett & Company sold out of Accendra Health (ACH) in Q4 2018, closing a stake of 1,050 shares — an estimated $17K sold.

Barnett & Company first reported a position in ACH in Q3 2018 and held it in 1 quarter. The position peaked at $17K in Q3 2018. 210 funds tracked by Wall St. Rank hold ACH as of Q4 2018.

Barnett & Company reported no remaining Accendra Health position as of Q4 2018 after selling out during the quarter.
Barnett & Company sold 1,050 Accendra Health shares in Q4 2018, an estimated $17K.
Barnett & Company first reported a position in Accendra Health in Q3 2018 and held it in 1 quarter.
Barnett & Company's Accendra Health position peaked at $17K in Q3 2018.
210 funds tracked by Wall St. Rank held Accendra Health as of Q4 2018.

Based on Barnett & Company's 13F filing for Q4 2018, filed 15 Feb 2019.